Recombinant multi-species SNX16 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNX16 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the sorting nexin family. Members of this family contain a phox (PX) domain, which is a phosphoinositide binding domain, and are involved in intracellular trafficking. The protein encoded by this gene associates with late endosome membranes as is involved in tubule formation, cholesterol transport, and transport of tetraspanin CD81. The encoded protein also inhibits cell migration and tumorigenesis. [provided by RefSeq, Jan 2017]
The Alternative Names of target: 4930522N22Rik,SNX16,Snx16,Sorting nexin-16

Target products collectionGo to SNX16 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11105-Ag-1/ GM-Tg-hg-IP11105-Ag-2 Human SNX16 protein Human
GM-Tg-rg-IP11105-Ag-1/ GM-Tg-rg-IP11105-Ag-2 Rat SNX16 protein Rat
GM-Tg-mg-IP11105-Ag-1/ GM-Tg-mg-IP11105-Ag-2 Mouse SNX16 protein Mouse
GM-Tg-cynog-IP11105-Ag-1/ GM-Tg-cynog-IP11105-Ag-2 Cynomolgus/Rhesus macaque SNX16 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11105-Ag-1/ GM-Tg-felg-IP11105-Ag-2 Feline SNX16 protein Feline
GM-Tg-cang-IP11105-Ag-1/ GM-Tg-cang-IP11105-Ag-2 Canine SNX16 protein Canine
GM-Tg-bovg-IP11105-Ag-1/ GM-Tg-bovg-IP11105-Ag-2 Bovine SNX16 protein Bovine
GM-Tg-equg-IP11105-Ag-1/ GM-Tg-equg-IP11105-Ag-2 Equine SNX16 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11105-Ag-1/ GM-Tg-hg-IP11105-Ag-2; GM-Tg-rg-IP11105-Ag-1/ GM-Tg-rg-IP11105-Ag-2;
GM-Tg-mg-IP11105-Ag-1/ GM-Tg-mg-IP11105-Ag-2; GM-Tg-cynog-IP11105-Ag-1/ GM-Tg-cynog-IP11105-Ag-2;
GM-Tg-felg-IP11105-Ag-1/ GM-Tg-felg-IP11105-Ag-2; GM-Tg-cang-IP11105-Ag-1/ GM-Tg-cang-IP11105-Ag-2;
GM-Tg-bovg-IP11105-Ag-1/ GM-Tg-bovg-IP11105-Ag-2; GM-Tg-equg-IP11105-Ag-1/ GM-Tg-equg-IP11105-Ag-2
Products Name SNX16 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SNX16
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SNX16 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.